STRS Ohio’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

STRS Ohio’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,900	Closed	-$38K	–	2010
2016 Q4	$38K	Hold	7,900	–	–	﹤0.01%	1826
2016 Q3	$39K	Sell	7,900 -300	-4%	-$1.53K	﹤0.01%	1796
2016 Q2	$41K	Hold	8,200	–	–	﹤0.01%	1803
2016 Q1	$46K	Hold	8,200	–	–	﹤0.01%	1773
2015 Q4	$85K	Hold	8,200	–	–	﹤0.01%	1714
2015 Q3	$151K	Buy	+8,200	New	+$158K	﹤0.01%	1580
2014 Q3	–	Sell	-7,400	Closed	-$106K	–	1899
2014 Q2	$116K	Buy	7,400 +6,100	+469%	+$89.7K	﹤0.01%	1537
2014 Q1	$17K	Hold	1,300	–	–	﹤0.01%	1688
2013 Q4	$21K	Buy	+1,300	New	+$20.7K	﹤0.01%	1705

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

STRS Ohio's OSIR Position: Q1 2017 in Review

STRS Ohio sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 7,900 shares — an estimated $38K sold.

STRS Ohio first reported a position in OSIR in Q4 2013 and held it in 9 quarters. The position peaked at $151K in Q3 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

STRS Ohio reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
STRS Ohio sold 7,900 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $38K.
STRS Ohio first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
STRS Ohio's Osiris Therapeutics, Inc. Common Stock position peaked at $151K in Q3 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on STRS Ohio's 13F filing for Q1 2017, filed 26 Apr 2017.